Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Metformin Hydrochloride Extended?Release Tablets USP, 500 mg and 1000 mg’, which is self explanatory.
The above information is a part of company’s filings submitted to BSE.